Combined targeted therapies, where to next

被引：0
|
作者：
Long, Georgina V. [1 ,2 ]
机构：
[1] Melanoma Inst Australia, Sydney, NSW, Australia
[2] Univ Sydney, Sydney, NSW 2006, Australia
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.MEL2014-IA30
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IA30
引用
收藏
页数：1
相关论文
共 50 条
  • [21] APOPTOSIS-TARGETED THERAPIES - THE NEXT BIG THING IN BIOTECHNOLOGY
    COHEN, JJ
    ALRUBEAI, M
    TRENDS IN BIOTECHNOLOGY, 1995, 13 (08) : 281 - 283
  • [22] Targeted therapies of gastrointestinal stromal tumors (GIST)-The next frontiers
    Duensing, Stefan
    Duensing, Anette
    BIOCHEMICAL PHARMACOLOGY, 2010, 80 (05) : 575 - 583
  • [23] The Next Frontier in Sarcoma: Molecular Pathways and Associated Targeted Therapies
    Kim, Ted
    Bui, Nam Q.
    CANCERS, 2023, 15 (06)
  • [24] Targeted therapies in medical oncology: successes, failures and next steps
    Mallarkey, Gordon
    Coombes, R. Charles
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2013, 5 (01) : 5 - 16
  • [25] Docetaxel combined with targeted therapies in metastatic breast cancer
    Cortes, Javier
    Roche, Henri
    CANCER TREATMENT REVIEWS, 2012, 38 (05) : 387 - 396
  • [26] Alzheimer's disease: where next for anti-amyloid therapies?
    Hardy, John
    De Strooper, Bart
    BRAIN, 2017, 140 : 853 - 855
  • [27] Mitosis-targeted anti-cancer therapies: where they stand
    K-S Chan
    C-G Koh
    H-Y Li
    Cell Death & Disease, 2012, 3 : e411 - e411
  • [28] Mitochondrial Targeted Therapies: Where Do We Stand in Mental Disorders?
    Ben-Shachar, Dorit
    Ene, Hila M.
    BIOLOGICAL PSYCHIATRY, 2018, 83 (09) : 770 - 779
  • [29] Mitosis-targeted anti-cancer therapies: where they stand
    Chan, K-S
    Koh, C-G
    Li, H-Y
    CELL DEATH & DISEASE, 2012, 3 : e411 - e411
  • [30] What's next in glioblastoma treatment: Tumor-targeted or immune-targeted therapies?
    Schernberg, Antoine
    Marabelle, Aurelien
    Massard, Christophe
    Armand, Jean-Pierre
    Dumont, Sarah
    Deutsch, Eric
    Dhermain, Frederic
    BULLETIN DU CANCER, 2016, 103 (05) : 484 - 498
12345